PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsatrioventricular nodal reentry tachycardia
MeSH D013611 - atrioventricular nodal reentry tachycardia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D054139:Reciprocating tachycardia
0 Companies
0 Drugs
Success rate
D013611: 
Atrioventricular nodal reentry tachycardia
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
American RegentAdenosine Adenosine  2009-04-28   
Astellas PharmaAdenosine Adenocard  1989-10-30   
Adenosine Adenoscan  1995-05-18   
Avet LifesciencesAdenosine Adenosine  2014-09-15   
Eugia Pharma SpecialtiesAdenosine Adenosine  2017-11-02   
Fresenius KabiAdenosine Adenosine  2005-04-27   
Gland PharmaAdenosine Adenosine  2007-06-14   
Hikma PharmaceuticalsAdenosine Adenosine  2004-06-16   
HospiraAdenosine Adenosine  2014-03-24   
Meitheal PharmaceuticalsAdenosine Adenosine  2013-08-29   
MylanAdenosine Adenosine  2014-03-21   
1
2
>
Clinical Trials
Historical Success Rate
No data
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Astellas Pharma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use